The Transcatheter Aortic Valve Implantation Registry (TAVI-R) was established in 2018 by the Australasian Cardiac Outcomes Registry (ACOR) Ltd as a clinical quality registry to monitor outcomes for patients undergoing Transcatheter Aortic Valve Implantation (TAVI), an interventional procedure used in the treatment of aortic stenosis. The registry is currently operated under contract by SAHMRI.
SAHMRI and ACOR collaborate closely to effectively maintain and oversee the registry of Transcatheter Aortic Valve Implantation (TAVI) procedures across Australia. With the valuable support of TAVI performing hospitals, clinicians, and device companies, the collected data serves multiple purposes. It not only facilitates continuous monitoring of the procedure’s safety and the effectiveness of the utilized devices but also fosters research opportunities aimed at enhancing patient care.
All hospitals that carry out TAVI procedures are eligible to contribute their data to the Registry. To ensure that a surgeon in Australia is qualified to perform TAVI procedures, please consult the guidelines titled “Position Statement for the Operator and Institutional Requirements for a Transcatheter Aortic Valve Implantation (TAVI) Program,” which are developed by CSANZ.
